abstract |
This disclosure provides compounds of formula (I) Among them A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16. W, X, and Y have any values defined in the specification, and provide pharmaceutically acceptable salts of such compounds, which can be used as medicaments for the treatment of diseases and disorders Including cancer. Also provided are pharmaceutical compositions comprising compounds of formula (I). |